12.07.22 -- What Astellas Learned About Decentralized Trials

When the COVID-19 pandemic hit in the spring of 2020, many companies were unprepared for the changes that were about to impact their studies. Astellas is one company that was better prepared than most. The company had initiated a formalized, internal project on decentralized clinical trial (DCT) technologies and their use in clinical trials about nine months prior to the pandemic.

Today, proactively incorporating community clinicians and sites into clinical research is the next step in broadening the reach and diversity of oncology studies while still generating high-quality data. Listen to this podcast to find out more.

Learn how hybrid and decentralized clinical trials can provide patients the opportunity to participate in a clinical trial and receive a treatment to which they would otherwise not have access.

For sponsors, discover how decentralized trials (DCTs) show promise for boosting recruitment and helping subject retention.

Clinical trials are becoming increasingly decentralized, and Q² Solutions is committed to discovering innovative ways of improving the patient and investigator experience.

When you consider the criteria that are most important to your trial success, PCM Trials comes out as a preferred choice time and time again. Why?

In “Better Than Expected — A Firsthand Experience In Africa,” Kamila Novak shared her positive impressions from visiting medical research centers in sub-Saharan Africa. However, the picture would not be complete without talking about the continent’s personal safety and professional security, regulatory landscape, and ongoing socioeconomic challenges.

Learn what sites, CROs, and patient advocacy groups are doing to make clinical trials accessible to the most at-risk patients and the solutions that can maximize diverse clinical trial enrollment.

Is the clinical trial setting the best environment to ensure a patient’s safety? Dr. Jamie P. Dwyer discusses how nephrology clinical trials identify future patient risk factors for medication and treatment in the real-world setting.

In the following interview, Cytel’s chief medical officer, Dr. Albert Kim, speaks with Dr. Esha Senchaudhuri to discuss many aspects of simulation-guided design – its abilities, its benefits, and so much more.   

Discover how to ensure your distribution plan is robust, how to best determine your depot requirements, how to efficiently adapt to study changes, as well as how COVID-19 may impact your distribution planning.

An IIT is a result of an investigator creating an idea for a study, developing the protocol, and serving as both the sponsor and the investigator for the trial. Discover why there is much to plan in order for it to run smoothly.

This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/IRT provides the ability to be as creative as needed.

Successfully sourcing commercial products for comparative studies in an effective and efficient manner often proves far more challenging than assumed.

This paper explores essential principles for defining the right strategy for natural history studies and how to design such studies in a way that the data can be used as an external comparator to augment future regulatory filings and payer submissions.

In Q1 2022, ISR surveyed 100 sponsors who outsource clinical logistics and asked them which activities they would like to source from a single service provider for a trial. Learn why clinical labeling, clinical supply chain management, and storage and distribution of clinical trial materials received the most votes.

The growing demand for comparators is causing many supply chain managers to explore available sourcing options. Explore alternative local sourcing strategies, including advantages and disadvantages.

Harbor Clinical has redefined the FSP service model, adding enhanced flexibility in timing, scope, and level of resources assigned. 

Marken provides a best-in-class quality management system, a global GMP depot network, direct-to/from-patient, home healthcare nursing services, and industry-leading expertise all under one single-source provider

Today’s complex clinical trials require reliable and experienced technical and operational support throughout a study. Watch this video to see how LabConnect has supported their clients in critical functions by providing biospecimen managers and scientists to drive successful outcomes.

As your clinical material partner, we simplify – and accelerate – your clinical trials. From assistance with time-consuming international documentation through destruction following all regulatory protocols, RPS is your trusted clinical trial partner.